Paper26319488
The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.
Samson P and 12 others. Ann Thorac Surg, 2015. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis. Papers, record 26319488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26319488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Health Care Costs | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasm Staging | Major topic |
| Pneumonectomy | Major topic |
| Cost-Benefit Analysis | |
| Humans | |
| Retrospective Studies |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K12-CA-167540-02 | NCI NIH HHS | United States | K12CA167540 | PubMed and NIH | NIH RePORTER |
| T32 CA009621 | NCI NIH HHS | United States | T32CA009621 | PubMed and NIH | NIH RePORTER |
| K12 CA167540 | NCI NIH HHS | United States | K12CA167540 | PubMed and NIH | NIH RePORTER |
| T32-CA-009621-25 | NCI NIH HHS | United States | T32CA009621 | PubMed and NIH | NIH RePORTER |
| K07 CA178120 | NCI NIH HHS | United States | K07CA178120 | PubMed and NIH | NIH RePORTER |
| P30 CA091842 | NCI NIH HHS | United States | P30CA091842 | PubMed and NIH | NIH RePORTER |
| T32 HL007776 | NHLBI NIH HHS | United States | T32HL007776 | PubMed and NIH | NIH RePORTER |
| K07-CA-178120 | NCI NIH HHS | United States | K07CA178120 | PubMed and NIH | NIH RePORTER |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15908042 | A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer. | Lung Cancer | 2005 | https://conductscience.org/library/papers/15908042 | PubMed |
| 2 | 12243809 | Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group. | Int J Radiat Oncol Biol Phys | 2002 | https://conductscience.org/library/papers/12243809 | PubMed |
| 3 | 17356099 | Updated evaluation of the cost-effectiveness of lung volume reduction surgery. | Chest | 2007 | https://conductscience.org/library/papers/17356099 | PubMed |
| 4 | 22169443 | A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. | J Thorac Cardiovasc Surg | 2012 | https://conductscience.org/library/papers/22169443 | PubMed |
| 5 | 18831506 | Cost comparison of robotic, video-assisted thoracic surgery and thoracotomy approaches to pulmonary lobectomy. | Thorac Surg Clin | 2008 | https://conductscience.org/library/papers/18831506 | PubMed |
| 6 | 14688709 | Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis. | J Thorac Cardiovasc Surg | 2003 | https://conductscience.org/library/papers/14688709 | PubMed |
| 7 | 19551884 | Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. | Cancer | 2009 | https://conductscience.org/library/papers/19551884 | PubMed |
| 8 | 19875976 | Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy. | J Thorac Oncol | 2009 | https://conductscience.org/library/papers/19875976 | PubMed |
| 9 | 19803556 | Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancer. | J Manag Care Pharm | 2009 | https://conductscience.org/library/papers/19803556 | PubMed |
| 10 | 22386614 | Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. | Heart Lung Circ | 2012 | https://conductscience.org/library/papers/22386614 | PubMed |
| 11 | 7497767 | The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group. | Chest | 1995 | https://conductscience.org/library/papers/7497767 | PubMed |
| 12 | 11064351 | High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma. | Cancer | 2000 | https://conductscience.org/library/papers/11064351 | PubMed |
| 13 | 23720093 | Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. | Cancer | 2013 | https://conductscience.org/library/papers/23720093 | PubMed |
| 14 | 24210834 | Comparing robot-assisted thoracic surgical lobectomy with conventional video-assisted thoracic surgical lobectomy and wedge resection: results from a multihospital database (Premier). | J Thorac Cardiovasc Surg | 2014 | https://conductscience.org/library/papers/24210834 | PubMed |
| 15 | 24018022 | Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities. | Lung Cancer | 2013 | https://conductscience.org/library/papers/24018022 | PubMed |
| 16 | 19049763 | Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. | Ann Thorac Surg | 2008 | https://conductscience.org/library/papers/19049763 | PubMed |
| 17 | 25439468 | Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes. | J Thorac Cardiovasc Surg | 2015 | https://conductscience.org/library/papers/25439468 | PubMed |
| 18 | 21228314 | Projections of the cost of cancer care in the United States: 2010-2020. | J Natl Cancer Inst | 2011 | https://conductscience.org/library/papers/21228314 | PubMed |
| 19 | 25085960 | Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. | Circulation | 2014 | https://conductscience.org/library/papers/25085960 | PubMed |
| 20 | 19632716 | Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. | Lancet | 2009 | https://conductscience.org/library/papers/19632716 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38505073 | Surgical-decision making in the setting of unsuspected N2 disease: a cost-effectiveness analysis. | J Thorac Dis | 2024 | https://conductscience.org/library/papers/38505073 | PubMed |
| 37624518 | Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based Study. | Ann Surg Oncol | 2023 | https://conductscience.org/library/papers/37624518 | PubMed |
| 36378625 | The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study. | PLoS One | 2022 | https://conductscience.org/library/papers/36378625 | PubMed |
| 36004217 | Select octogenarians with stage IIIa non-small cell lung cancer can benefit from trimodality therapy. | JTCVS Open | 2022 | https://conductscience.org/library/papers/36004217 | PubMed |
| 35687964 | Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities. | Curr Probl Cancer | 2022 | https://conductscience.org/library/papers/35687964 | PubMed |
| 33014826 | Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer. | Front Oncol | 2020 | https://conductscience.org/library/papers/33014826 | PubMed |
| 28964421 | A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. | Ann Thorac Surg | 2017 | https://conductscience.org/library/papers/28964421 | PubMed |
| 27844308 | Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base. | J Neurooncol | 2017 | https://conductscience.org/library/papers/27844308 | PubMed |
| 27293147 | Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. | Ann Thorac Surg | 2016 | https://conductscience.org/library/papers/27293147 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26319488
GET https://conductscience.org/api/papers/v1/26319488/references?page=2